For organ transplant recipients, understanding the relationship between their life-saving procedure and potential lymphoma ...

Certain epidemiologic features of infectious mononucleosis are indicated by antibody patterns to the EB or herpes-like virus of Burkitt lymphoma. The absence of antibody correlated well with ...

Antiretroviral therapy has decreased the risk of lymphoma in the HIV-positive patient ... lymphomas are associated with oncogenic viruses (EBV and Kaposi sarcoma-associated herpes virus), there ...

Reprioritized resources to reduce costs and enhance focus on Nana-val’s development program in relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) - - On track to report data from ...

Viracta Therapeutics, Inc. ( (VIRX) ) has released its Q3 earnings. Here is a breakdown of the information Viracta Therapeutics, Inc. presented ...

Neoplasms associated with EBV infection are EBV-positive Hodgkin lymphoma (HL), EBV-associated Burkitt lymphoma, diffuse ...

These include a potentially registrational Phase 2 basket trial for various subtypes of EBV-positive lymphoma and a Phase 1b/2 trial for recurrent or metastatic EBV-positive nasopharyngeal ...

Reprioritized resources to reduce costs and enhance focus on Nana-val’s development program in relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) - - On track to report data ...

“Last quarter, based on productive feedback from FDA, we announced a sharpened focus on the second-line EBV-positive PTCL subpopulation ... EBV-targeted therapy for lymphoma patients, subject ...

Reprioritized resources to reduce costs and enhance focus on Nana-val's development program in relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) - - On track to report data ...